CIK 0001761918 · <br>Emerging growth company
Erasca, Inc.
Sign in to watch- Ticker
- ERAS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831217027
- Phone
- (858) 465-6511
- Business address
- 3115 MERRYFIELD ROW, THIRD FLOOR, SAN DIEGO, CA, 92121
- 4 Derivatives Options or other derivatives
- 4 Other acquisition Chief Financial Officer acquired 1,750 shares (other)
- 4 Other acquisition Chief Medical Officer acquired 1,750 shares (other)
- 4 Other acquisition General Counsel & Corp. Sec. acquired 2,390 shares (other)
- 4 Open-market buy Chairman & CEO bought 60,000 shares at $3.86 ($231,420)
- 4 Open-market buy Director bought 10,000 shares at $4.64 ($46,400)
- 4 Open-market buy Director bought 20,000 shares at $4.14 ($82,800)
- 4/A Open-market buy Director bought 307,692 shares at $6.50 ($1,999,998)
- 4 Open-market buy Director bought 307,692 shares at $6.50 ($1,999,998)
- 4 Open-market buy Director bought 20,000 shares at $4.87 ($97,490)
- 4 Open-market buy Chairman & CEO bought 40,000 shares at $4.99 ($199,600)
- 4 Other disposition Director disposed of 750,000 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 5 of 7 · 127 filings